Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar;30 Suppl(0):S26-31.
doi: 10.1016/j.bbi.2012.10.022. Epub 2012 Nov 16.

The influence of glucocorticoid signaling on tumor progression

Affiliations
Review

The influence of glucocorticoid signaling on tumor progression

Paul A Volden et al. Brain Behav Immun. 2013 Mar.

Abstract

The diagnosis of cancer elicits a broad range of well-characterized stress-related biobehavioral responses. Recent studies also suggest that an individual's neuroendocrine stress response can influence tumor biology. One of the major physiological pathways altered by the response to unrelenting social stressors is the hypothalamic-pituitary-adrenal or HPA axis. Initially following acute stress exposure, an increased glucocorticoid response is observed; eventually, chronic stress exposure can lead to a blunting of the normal diurnal cortisol pattern. Interestingly, recent evidence also links high primary tumor glucocorticoid receptor expression (and associated increased glucocorticoid-mediated gene expression) to more rapid estrogen-independent breast cancer progression. Furthermore, animal models of human breast cancer suggest that glucocorticoids inhibit tumor cell apoptosis. These findings provide a conceptual basis for understanding the molecular mechanisms underlying the influence of the individual's stress response, and specifically glucocorticoid action, on breast cancer and other solid tumor biology. How this increased glucocorticoid signaling might contribute to cancer progression is the subject of this review.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Dr. Conzen has a patent application pending proposing the use of glucocorticoid receptor antagonism in breast cancer. There is no financial conflict of interest.

Figures

Fig. 1
Fig. 1
The multi-layered environments of tumor growth within an individual. The malignant cell environment exists within a nested series of environments capable of varying levels of reciprocal communication. The stressors and support systems of an individual’s social environment (dark gray) can interact with an individuals psychological environment (dark pink) to impact the physiology of the systemic environment (pale gray). These physiological changes can promote tumor progression by directly affecting tumor biology or indirectly though the microenvironment (pale pink). Transdisciplinary research considers all five environments through the coordinated experiments of both social and biological scientists using unifying model systems.

References

    1. Adzic M, Djordievic J, Djordievic A, Niciforovic A, Demonacos C, Radojcic M, Krstic-Demonacos M. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol. 2009;202:87–97. - PMC - PubMed
    1. Andersen BL, Yang HC, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton LM, Young DC, Carson WE. Psychologic intervention improves survival for breast cancer patients a randomized clinical trial. Cancer. 2008;113:3450–3458. - PMC - PubMed
    1. Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immun. 2009;23:10–15. - PMC - PubMed
    1. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res. 2002;52:1–23. - PubMed
    1. Cao L, Liu XL, Lin EJD, Wang CS, Choi EY, Riban V, Lin B, During MJ. Environmental and genetic activation of a brain-adipocyte BDNF/Leptin axis causes cancer remission and inhibition. Cell. 2010;142:52–64. - PMC - PubMed

Publication types

MeSH terms